The Adult Malignant Glioma Therapeutics Market is gaining significant momentum due to the rising burden of aggressive brain tumors and the increasing demand for advanced oncology treatments. According to insights from The Insight Partners, the Adult Malignant Glioma Therapeutics Market is projected to reach US$ 5.39 billion by 2031, registering a CAGR of 9.8% during 2025–2031. The strong...